Source: Tanjug | Thursday, 01.01.1970.| 11:50
Highlight an article Print out the news

Vaccine against uterine cancer soon on market of Serbia?

Company "Merck Sharp & Dohme" (MSD), which has been present on the local market since 1996, works on the obtaining of the approval for sale of revolutionary vaccine against uterine cancer named "Silgard" in Serbia.

Let us remind that the Advisory Board for Immunization of the American CEnter for Control and Prevention of Diseases unanimously backed the recommendation that the girls and women, aged between 11 and 26, should be vaccinated with the MSD vaccine, which is called "gardasil" in USA. Company "Merck" tested "gardasil" on 27,000 women in 33 countries and the results of the clinical testing showed that the vaccine was 100% efficient aggainst the viruses that are responsilbe for 70% of infections caused by human papilloma virus.

By the way, the uterine cancer is the second most often type of that women's disease. Every year, half million new cases are registered.

Only logged-in users can comment.
Follow the news, tenders, grants, legal regulations and reports on our portal.
Testiraj besplatno!
Register for our daily business bulletin, which is sent to your email address at the end of each work day.
Full information is available only to commercial users-subscribers and it is necessary to log in.
Test for free!
Testiraj besplatno!
Full information is available to commercial users-subscribers only.
Testiraj besplatno!

Log in to view complete information:
Forgot your password? Click here HERE
For free test use, click HERE